Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options

International Journal of Cardiology

Volumn 58, Issue 2, 1997, Pages 95-117

  Maxwell, Simon R J ^a   Lip, Gregory Y H ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

free radicals; myocardial ischaemia; reperfusion injury

Indexed keywords

3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; CALCIUM ANTAGONIST; CAPTOPRIL; CATALASE; CHELATING AGENT; COPPER; CREATINE PHOSPHATE; DEFEROXAMINE; DIMETHYLTHIOUREA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; IBUPROFEN; LIDOFLAZINE; MAGNESIUM; MANNITOL; OXIPURINOL; PROBUCOL; PROPIONYLCARNITINE; RIBOFLAVIN; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; UBIQUINONE; XANTHINE OXIDASE INHIBITOR;

HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0031055348     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02854-9     Document Type: Article

References (237)

1. McCord JM. Oxygen-derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985; 312: 159-163.
2. Patterson CE, Rhoades RA. Protective role of sulfhydryl reagents in oxidant lund injury. Exp Lung Res 1988; 14: 1005-1019.
3. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischaemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 1989; 13: 450-459.
4. Engler RL, Dahlgren MD, Morris DD, Petersen MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischaemia and reflow in dogs. Am J Physiol 1986; 251: H314-H322.
5. Maxwell L, Gavin JB. The role of post-ischaemic reperfusion in the developmemt of microvascular incompetence and ultrastructural damage in the myocardium. Basic Res Cardiol 1991; 86: 544-553.
6. Forman MB, Bingham S, Kopelman HA et al. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1985; 71: 1060-1068.
7. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischaemia: relevance to reperfusion. J Am Coll Cardiol 1988; 11: 1309-1316.
8. Williams FM, Collins PD, Tanniere-Zeller M, Williams TJ. The relationship between neutrophils and increased microvascular permeability in a model of myocardial ischaemia and reperfusion in the rabbit. Br J Pharmacol 1990; 100: 729-734.
9. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986; 74: 1424-1433.
10. Ryan T, Tarver RD, Duerk JL et al. Distinguishing viable from infarcted myocardium after experimental ischaemia and reperfusion by using nuclear magnetic resonance imaging. J Am Coll Cardiol 1990; 15: 1355-1364.
11. Knabb RM, Bergmann SR, Fox KAA, Sobel BE. The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med 1987; 28: 1563-1570.
12. Sobey CG, Dalipram RA, Dusting GJ, Woodman OL. Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol. Br J Pharmacol 1992; 105: 557-562.
13. McFalls EO, Duncker DJ, Krams R, Ward H, Gornick C, Verdouw PD. Endothelium dependent vasodilatation following brief ischaemia and reperfusion in anaesthetised swine. Cardiovasc Res 1991; 25: 659-665.
14. Lefer AM, Johnson G, Ma XL, Tsao PS, Thomas GR. Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 1991; 103: 1153-1159.
15. Lefer AM, Aoki N, Mulloy D. Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion. Naunyn Schmiederberg's Arch Pharmacol 1990; 341: 246-250.
16. Lum HL, Barr DA, Shaffer JR, Gordon RJ, Ezrin AM, Malik AB. Reoxygenation of endothelial cells increases permeability by oxygen-dependent mechanisms. Circ Res 1992; 70: 991-998.
17. Sheridan FM, Dauber IM, McMurty IF, Lesnefsky EJ, Horwitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischaemia and reperfusion. Circ Res 1991; 69: 1566-1574.
18. Arroyo CM, Carmichael AJ, Bouscarel B, Liang JH, Weglicki WB. Endothelial cells as a source of oxygen radicals. An ESR study. Free Radic Res Commun 1990; 9: 287-296.
19. Mak IT, Boehme P, Weglicki WP. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res 1992; 70: 1099-1103.
20. Hearse DJ, Humphrey SM, Nayler WG, Sale A, Border Z. Ultrastructural damage associated with reoxygenation of anoxic myocardium. J Mol Cell Cardiol 1975; 7: 315-324.
21. Hearse DJ, Manning AS, Downey JM, Yellon DM. Xanthine oxidase: a critical mediator of myocardial injury during ischaemia and repertusion? Acta Physiol Scand 1986; 548: 65-74.
22. Brown EJ Jr, Swinford RD, Gadde P, Lills O. Acute effects of delayed reperfusion on myocardial infarct shape and left ventricular volume: a potential mechanism of additional benefits from thrombolytic therapy. J Am Coll Cardiol 1991; 17: 1641-1650.
23. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1993; 21: 683-691.
24. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992; 26: 101-108.
25. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311-322.
26. Ceriana P. Effect of myocardial ischaemia-reperfusion on granulocyte elastase release. Anaesth Int Care 1992; 20: 187-190.
27. Ferrari R, Curello S, Boffa GM, Condorelli E, Pasini E, Guanieri G, Albertini A. Oxygen free radical-mediated heart injury in animal models and during bypass surgery in humans. Effects of alpha-tocopherol. Ann NY Acad Sci 1989; 570: 237-253.
28. Ferrari R, Ceconi C, Curello S, Cargoni A, De-Guioli F, Visioli O. Occurrence of oxidative stress during myocardial reperfusion. Mol Cell Biochem 1992; 111: 61-69.
29. Hasin Y, Kneen MM, Craik DJ, Nayler WG. Relationship between ATP resynthesis and calcium accumulation in the reperfused rat heart. Clin Exp Pharmacol Physiol 1992; 19: 79-87.
30. Wolfe CL, Donnelly TJ, Sievers R, Parmley WW. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia. Cardiovasc Res 1991; 25: 101-109.
31. Mouton R, Huisamen B, Lochner A. The effect of ischaemia and reperfusion on sarcolemmal inositol phospholipid and cytosolic inositol phosphate metabolism in the isolated perfused rat heart. Mol Cell Biochem 1991; 105: 127-135.
32. Aceto A, Mezzetti A, Di Ilio C, Calafiore AM, De Cesare D, Bosco G, Acciai N, Cappalletti L, Federici G, Cuccurullo F. Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and glutathione transferase activities in human heart protected by hypothermic cardioplegia. Free Radic Res Commun 1990; 8: 85-91.
33. Recknagel RO, Glende AE. Spectrophotometric determination of lipid conjugate dienes. Methods Enzymol 1984; 105: 331.
34. Yagi K. Assay of lipid peroxides in blood plasma or serum. Methods Enzymol 1984; 105: 328.
35. Ambrosio G, Flaherty JT, Duilio C et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991; 87: 2056-2066.
36. Romaschin AD, Wilson GJ, Thomas U, Feitler DA, Tumiata L, Mickle DAG. Sucellular distribution of peroxidized lipids in myocardial reperfusion injury. Am J Physiol 1990; 259: H116-H123.
37. Oldroyd KG, Paterson JR, Rumley AG, Eleiba H, Rae AP, Shepherd J, Cobbe SM, Hutton I. Coronary venous lipid peroxide concentrations after coronary angioplasty correlation with biochemical and electrocardiographic evidence of myocardial ischaemia. Br Heart J 1992; 68: 43-47.
38. Roberts MJD, Young IS, Trouton TJ, Trimble ER, Khan MM, Webb SW, Wilson CM, Patterson GC, Adgey AAJ. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 1990; 336: 143-145.
39. Scheerder IK, van der Kraaij AM, Lamers JM, Koster JF, Serruys PW. Malondialdehyde and uric acid release as a result of PTCA. J Am Coll Cardiol 1990; 15: 47A [abstract].
40. Dart RC, Sanders AB. Oxygen free radicals and myocardial reperfusion injury. Ann Emerg Med 1988; 17: 53-58.
41. Guarnieri C, Flamigini F, Caldarera CM. Role of oxygen in cellular damage induced by reoxygenation of hypoxic heart. J Mol Cell Cardiol 1980; 12: 797-808.
42. Shah B, Sobotka PA, Utser B, Zarling EJ, Thomas JX. Butane release from the reperfused ischaemic rat heart. Circulation 1989; 80: II-33 A129.
43. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Timmis AD. Lipid peroxidation associated with successful thrombolysis. Lancet 1990; 335: 741-743.
44. Grech ED, Jack CIA, Bleasdale C, Jackson MJ, Hind CRK, Perry RA. Differential free radical activity (FRA) after successful and unsuccessful thrombolytic reperfusion in acute myocardial infarction. Lancet 1993; 341: 990-991.
45. Bolli R, Jeroudi MO, Patel BS et al. Marked reduction of free radical generation and contractile dysfunction by anti-oxidant therapy begun at the time of reperfusion: evidence that myocardial 'stunning' is a manifestation of reperfusion injury. Circ Res 1989; 65: 607-622.
46. Blann AD, Midgley HS, Burrows G, Maxwell S, Utting S, Davies M, Waite MA, McCollum C. Free radicals, anti-oxidants and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coron Artery Dis 1993; 4: 905-910.
47. Shuter SL, Davies MJ, Garlick PB, Hearse DJ, Slater TF. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy. Free Radic Res Commun 1990; 9: 223-232.
48. Steg PG, Pasquier C, Pham T et al. Evidence for neutrophil and complement activation early after PTCA. J Am Coll Cardiol 1990; 15: 164A.
49. Paterson JR, Oldroyd K, Rumley AG et al. Free radical activity during percutaneous transluminal coronary angioplasty. Biochem Soc Trans 1990; 18: 1183-1184.
50. Coghlan JG, Flitter WD, Holley AE, Norell M, Mitchell AG, Ilsley CD, Slater TF. Detection of free radicals and cholesterol hydroperoxides from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free Radic Res Commun 1991; 14: 409-417.
51. Oldroyd KG, Chopra M, Rankin AC, Belch JJF, Cobbe SM. Lipid peroxidation during myocardial ischaemia induced by pacing. Br Heart J 1990; 63: 88-92.
52. Lau CS, Hill A, Scott NA, Forbes CD, Belch JJF. Increased release of malondialdehyde, a product of lipid peroxidation, following percutaneous baloon angioplasty. Clin Sci 1991; Suppl: 3P.
53. Lau CS, Hill A, Scott NA, Shaw JW, Belch JJF. Increased activity of oxygen free radicals during reperfusion in patients with peripheral arterial disease undergoing percutaneous peripheral artery balloon angioplasty. Int Angiol 1991; 10: 244-246.
54. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during myocardial infarction. Lancet 1991; 337: 933-935.
55. Basu DK, Karmazyn M. Injury to rat hearts produced by an exogenous radical generating system. Study into the role of arachidonic acid and eicosanoids. J Pharmacol Exp Ther 1987; 242: 673-685.
56. Blaustein AS, Schine L, Brooks WW, Franburg BL, Bing OH. Influence of exogenously generated oxidant species on myocardial function. Am J Physiol 1986; 250: H595-H599.
57. Hess ML, Okabe E, Kontos HA. Proton and free oxygen radical interaction with calcium transport system of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 1981; 13: 767-772.
58. Hearse DJ, Tosaki A. Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-arrhythmias in the rat heart. J Moll Cell Cardiol 1988; 20: 213-223.
59. Delbarre B, Floyd RA, Belbarre G, Calinon F. Glutamate accumulation and increased hydroxyl free radical formation in the abdominal aorta and heart of the gerbil after ischemia/ reperfusion insult. Free Radic Biol Med 1992; 13: 31-34.
60. Kramer JH, Arroyo CM, Dickens BF, Weglicki WB. Spin-trapping evidence that graded myocardial ischaemia alters post-ischaemic superoxide production. Free Radic Biol Med 1987; 3: 153-159.
61. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischaemic myocardium. Proc Natl Acad Sci USA 1987; 84: 1404-1407.
62. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757-760.
63. Bolli R, Jeroudi MO, Patel BS et al. Direct evidence that oxygen-derived free radicals contribute to post-ischaemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989; 86: 4695-4699.
64. Blasig IE, Ebert B, Hennig C, Pali T, Tosaki A. Inverse relationship between ESR spin-trapping of oxy-radicals and degree of functional recovery during myocardial reperfusion in isolated working rat heart. Cardiovasc Res 1990; 24: 263-270.
65. Roy RS, McCord JM. Superoxide and ischaemia: conversion of xanthine dehydrogenase to xanthine oxidase. In: Greenwald R, Cohen G, eds. Oxy-radicals and their Scavenger Systems. Vol 2. Cellular and Molecular Aspects. New York: Elsevier Science, 1983; 145-153.
66. Chambers DE, Parks DA, Patterson G et al. Xanthine oxidase as a source of free radical damage in myocardial ischaemia. J Mol Cell Cardiol 1985; 17: 145-152.
67. Schaffer SW, Roy RS, McCord JM. Possible role for calmodulin in calcium paradox-induced heart failure. Eur Heart J 1983; 4: H81-H87.
68. DeWall RA, Vasko KA, Stanley EL, Kezdi P. Responses of ischaemic myocardium to allopurinol. Am Heart J 1971; 82: 362-370.
69. Kopacz M, Karwatowska-Prokopczuk E, Beresewicz A. Reperfusion arrhythmias and purine washout in isolated rat and rabbit heart. Effect of allopurinol, dimethylthiourea and calcium reduction. J Mol Cell Cardiol 1993; 25: 859-874.
70. Babior BM. Oxygen dependent microbial killing by phogocytes. N Engl J Med 1978; 298: 659-668.
71. Dahinden CA, Fehr J, Hugli T. Role of cell surface contact in the kinetics of superoxide production by granulocytes. J Clin Invest 1983; 72: 113-121.
72. Fletcher MP, Seligmann BE, Gallin JI. Correlation of human neutrophil secretion, chemoattractant receptor mobilization and enhanced functional capacity. J Immunol 1982; 128: 941-948.
73. Edwards SW, Hallett MB, Campbell AK. Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J 1984; 217: 851-854.
74. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78: 651-655.
75. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP, Lucchesi BR. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion. Circ Res 1988; 63: 1070-1079.
76. Simpson PJ, Todd RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (Anti-MO1, Anti-CD 116) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624-629.
77. Boveris A, Cadenas E, Stoppani AOM. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976; 156: 435-444.
78. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980; 191: 421-427.
79. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinance is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem, Biophys 1982; 237: 408-414.
80. Watanabe F, Hashimoto T, Tagawa KJ. Energy independent protection of the oxidative phosphorylation capacity of mitochondria against anoxic damage by ATP and its non-metabolizable analogs. J Biochem 1985; 97: 1229-1234.
81. Piper HM. Energy deficiency, calcium overload or oxidative stress: possible causes of irreversible ischaemic myocardial injury. Klin Wochenschr 1989; 67: 465-476.
82. Parr DR, Wimhurst JM, Harris EF. Calcium-induced damage of rat heart mitochondria. Cardiovasc Res 1975; 9: 372.
83. Vlessis AA, Miler-Riker L. Potential role of mitochondrial calcium metabolism during reperfusion injury. Am J Physiol 1989; 256: C1196-C1206.
84. Singal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983; 161: 391-401.
85. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982; 60: 1390-1397.
86. Wheatley AM, Thandroyen FT, Opie LY. Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome. J Mol Cell Cardiol 1985; 17: 349-359.
87. Opie LH, Thandroyen FT, Muller C, Bricknell OL. Adrenaline-induced 'oxygen-wantage' and enzyme release from working heart. Effects of calcium antagonism, β-blockade, nicotinic acid and coronary artery ligation. J Mol Cell Cardiol 1979; 11: 1073-1094.
88. Matsuki T, Shirato O, Cohen MV, Downey JM. Oxypurinol limits myocardial infarct size in closed chest without pretreatment. Can J Cardiol 1990; 6: 123-129.
89. Jewett SL, Eddy LJ, Hochstein P. Is the autoxidation of catecholamines involved in ischaemia-reperfusion injury? Free Radic Biol Med 1989; 6: 185-188.
90. Halliwell B. Superoxide-dependent formation of hyotoxyl radicals in the presence of iron chelates. Is it a mechanism for hydroxyl radical production in biological systems. FEBS Lett 1978; 92: 321-326.
91. McCord JM, Day ED. Superoxide-dependent production of hydroxyl radical catalyzed by iron EDTA complex. FEBS Lett 1978; 86: 139-142.
92. Healing G, Gower J, Fuller B, Green C. Intracellular iron redistribution. An important determinant of reperfusion damage to rabbit kidneys. Biochem Pharmacol 1990; 39: 1239-1245.
93. Myers CL, Weiss SJ, Kirsh MM, Shlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the 'oxygen paradox': reduction of creatine kinase release by catalase, allopurinol or deferoxamine but not by superide dismutase. J Mol Cell Cardiol 1985; 17: 675-685.
94. Jugdutt BI. Delayed effects of early infarct-limiting therapies on healing after myocardial infarction. Circulation 1985; 72: 907-914.
95. Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987; 110: 13-30.
96. Klein HH, Pich S, Bohle RM et al. Anti-inflammatory agent BW 755c in ischaemic reperfused porcine hearts. J Cardiovasc Pharmacol 1988; 12: 338-344.
97. Stahl LD, Weiss HR, Becker LC. Myocardial oxygen consumption, oxygen supply/demand heterogeneity, and microvascular patency in regionally stunned myocardium. Circulation 1988; 77: 865-872.
98. Laxson DD, Homans DC, Dai X-Z, Sublett E, Bache RJ. Oxygen consumption and coronary reactivity in post-ischaemic myocardium. Circ Res 1989; 64: 9-20.
99. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischaemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133-1142.
100. Benzi RH, Lerch R Dissociation between contractile function and oxidative metabolism in post-ischaemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circ Res 1992; 71: 567-576.
101. Huang XQ, Ledtke AJ. Alterations in fatty acid oxidation in ischaemic and reperfused myocardium. Moll Cell Biochem 1989; 88: 145-153.
102. Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML, Marban E. Excitation-contraction coupling in post-ischaemic myocardium. Does failure of activator calcium transients underlie stunning? Circ Res 1990; 66: 1268-1276.
103. Trach V, Buschmans-Denkel E, Schaper W. Relation between lipolysis and glycolysis during ischaemia in the isolated rat heart. Basic Res Cardiol 1986; 81: 454-464.
104. i in perfused hearts: critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischaemia and reperfusion. Circ Res 1990; 66: 1255-1267.
105. Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischaemic reperfused myocardium. Am J Cardiol 1980; 46: 242-248.
106. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992; 20: 118-127.
107. Stewart JR, Blackwell WH, Crute SL, Loughlin V, Hess ML, Greenfield LJ. Prevention of myocardial ischaemia/ reperfusion injury with oxygen free-radical scavengers. Surg Forum 1982; 33: 317-320.
108. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049-1092.
109. Braunwald E, Kloner RA. The stunned myocardium-prolonged post-ischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149.
110. Bolli R. Mechanism of myocardial 'stunning'. Circulation 1990; 82: 723-738.
111. Bolli R. Oxygen-derived free radicals and post-ischaemic myocardial dysfunction ('stunned myocardium'). J Am Coll Cardiol 1988; 12: 239-249.
112. Farber NE, Vercellotti GM, Jacob HS, Pieper GM, Gross GJ. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the heart. Circ Res 1988; 63: 351-360.
113. Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA. Nifedipine administration after reperfusion abates systolic contractile dysfunction of post-ischaemic 'stunned' myocardium. J Am Coll Cardiol 1989; 13: 1176-1183.
114. Kloner RA, Allen J, Cox TA et al. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol 1991; 68: 329-334.
115. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982; 7: 1497-1503.
116. Wijns W, Serruys PW, Slager CJ et al. Effect of coronary occlusion during percutaneous transluminal coronary angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J Am Coll Cardiol 1986; 7: 455-463.
117. Schmidt WG, Sheehan FH, von Essen R et al. Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction. Am J Cardiol 1989; 63: 497-502.
118. Ferrari R, Alfieri O, Curello S et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990; 81: 201-211.
119. Fox KAA. Reperfusion injury: laboratory phenomenon or clinical reality? Cardiovasc Res 1991; 26: 656-659.
120. Charlat ML, O'Neill PG, Egan JM et al. Evidence for the pathogenetic role of xanthine oxidase in the 'stunned' myocardium. Am J Physiol 1987; 252: H566-H577.
121. Westlin W, Mullin KM. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989; 80: 1828-1836.
122. Engler RL, Covell JW Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischaemia in the dog. Circ Res 1987; 61: 20-28.
123. Cumming DVE, Holmberg SRM, Kusama Y et al. Effects of reactive oxygen species on the structure and function of the calcium-release channel from isolated sheep cardiac sarcoplasmic reticulum. J Physiol 1990; 420: 88.
124. Poole-Wilson PA, Holmberg SR, Williams AJ. A possible molecular mechanism for 'stunning' of the myocardium. Eur Heart J 1991; 12: 25-29.
125. Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML, Marban E. Excitation-contraction coupling in post-ischaemic myocardium. Does failure of activator calcium transients underlie stunning? Circ Res 1990; 66: 1268-1276.
126. Figueredo VM, Dresdner KP, Wolney AC, Keller AM. Postischaemic reperfusion injury in the isolated rat heart: effect of ruthenium red. Cardiovasc Res 1991; 25: 337-342.
127. Bavaria JE, Furakawa S, Kreiner G et al. Myocardial oxygen utilization after reversible global ischaemia. J Thorac Cardiovasc Surg 1990; 100: 210-220.
128. Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of superoxide dismutase and catalase in stunned myocardiium of dogs. Am J Physiol 1986; 250: H372-H377.
129. Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. N-2-Menaptopropronylglyane improves recovery of myocardial function after reversible regional ischaemia.
130. Bolli R, Zhu WX, Hartley CJ et al. Attenuation of dysfunction in the postischaemic 'stunned' myocardium by dimethylthiourea. Circulation 1987; 76: 458-468.
131. Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. Enhancement of recovery of myocardial function by oxygen free radical scavengers after reversible myocardial ischaemia. Circulation 1985; 72: 915-921.
132. Yamazaki S, Fujibayashi Y, Rajagopalan RE, Meerbaum S, Corday E. Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog. J Am Coll Cardiol 1986; 7: 564-572.
133. Bernier M, Manning AS, Hearse DJ. Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am J Physiol 1989; 256: H1344-H1352.
134. Balke CW, Kaplinski E, Michelson EL et al. Reperfusion tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischaemia. Am Heart J 1981; 101: 449-456.
135. Dutta SN, Booker WM. Possible myocardial adaption to acute coronary occlusion: relation to catecholamines. Arch Int Pharmacodyn Ther 1970; 185: 5-12.
136. Sewell WH, Koth DR, Hugging CE. Ventricular fibrillation in dogs after sudden return of flow to the coronary artery. Surgery 1955; 38: 1050-1053.
137. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: possible mechanisms and prevention. J Mol Cell Cardiol 1984; 16: 497-518.
138. McNeill AJ, Flannery DJ, Wilson CM et al. Thrombolytic therapy within one hour of onset of myocardial infarction. Q J Med 1991; 79: 487-494.
139. Roth A, Barbash GI, Hod D et al. Should thrombolytic therapy be administered in mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol 1990; 15: 932-936.
140. Osada M, Sato T, Komori S, Tamura K. Protective effect of preconditioning on reperfusion induced ventricular arrhythmias of isolated rat hearts. Cardiovasc Res 1991; 25: 441-444.
141. European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-389.
142. Cercek B, Lew AS, Laramee P, Shah PK, Peter TC, Ganz W. Time course and characteristics of ventricular arrhythmias after reperfusion in acute myocardial infarction. Am J Cardiol 1987; 60: 214-218.
143. Goldberg S, Greenspon AJ, Urban PL et al. Reperfusion arrhythmia: a marker of restoration of anterograde flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1983; 105: 26-32.
144. Khaja F, Walto JA, Brymer JF et al. Intracoronary fibrinolytic therapy in acute myocardial infarction: report of a prospective randomized trial. N Engl J Med 1983; 308: 1305-1311.
145. de Lorgeril M, Basmadjian A, Clement R, Rousseau G, Latour JG. Influence of reflow ventricular fibrillation and electrical defibrillation on infarct size in a canine preparation of myocardial infarction. Cardiovasc Res 1990; 24: 151-155.
146. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with 'anti-free radical' interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986; 58: 331-340.
147. Opie LH, Coetzee WA. Role of calcium ions in reperfusion arrhythmias. Relevance to pharmacological intervention. Cardiovasc Drugs Ther 1988; 2: 623-636.
148. Hearse DJ, Tosaki A. Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-arrhythmias in the rat heart. J Moll Cell Cardiol 1988; 20: 213-223.
149. Bernier M, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms of protection by glucose and mannitol. Am J Physiol 1988; 254: H862-H870.
150. Riva E, Manning AS, Hearse DJ. Superoxide dismutase and the reduction of reperfusion-induced arrhythmias: in vivo dose-response studies in the rat. Cardiovasc Drug Ther 1987; 1: 133-139.
151. Woodward B, Zakaria MNM. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985; 17: 485-493.
152. Nejima J, Knight DR, Fallon JT et al. Superoxide dismuatase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 79: 143-153.
153. Watanabe N, Inoue M, Morino Y. Inhibition of post ischaemic reperfusion arrhythmias by an SOD derivative that circulates blund to albumin with prolonged in vivo half life. Biochem Pharmacol 1989; 79: 143-153.
154. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992; 26: 101-108.
155. Coetzee WA, Owen P, Dennis SC, Saman S, Opie LH. Reperfusion damage: free radicals mediate delayed membrane changes rather than early ventricular arrhythmias. Cardiovasc Res 1990; 24: 156-164.
156. Curtis MJ. The rabbit dual coronary reperfusion model: a new method for assessing the pathological relevance of individual products of the ischaemic milieu: role of potassium in arrhythmogenesis. Cardiovasc Res 1991; 25: 1010-1025.
157. Kurz T, Yamada KA, DaTorre SD, Corr PB. Alpha-1-adrenergic system and arrhythmias in ischaemic heart disease. Eur Heart J 1991; 12: 88-98.
158. Mauri F, De Biase AM, Franzosi MG et al. In-hospital causes of death in the patients admitted to the GISSI study. G Ital Cardiol 1987; 17: 37-44.
159. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-1136.
160. Downey JM. Ischemic preconditioning: nature's own cardioprotective intervention. Trends Cardiovasc Med 1992; 2: 170-176.
161. Zweir Jl, Kuppusamy P, Williams R et al. Measurement and characterization of post-isonemic free radical generation in the isolated perfused heart. J Biol Chem 1989; 264: 18890-18895.
162. Bolli R, Jeroudi MO, Patel BS et al. Direct evidence that oxygen-derived free radicals contribute to post-ischaemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989; 86: 4695-4699.
163. Johansson MH, Deinum J, Marklund SL, Sjodquist PO. Recombinant human extracellular superoxide dismutase reduces concentration of oxygen free radicals in the reperfused rat heart. Cardiovasc Res 1990; 24: 500-503.
164. Blaustein AS, Schine L, Brooks WW, Franburg BL, Bing OH. Influence of exogenously generated oxidant species on myocardial function. Am J Physiol 1986; 250: H595-H599.
165. Shlafer M, Kane PF, Wiggins VY. Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischaemic injury. Circulation 1982; 66: 85-95.
166. Casale AS, Bulkley GB, Bulkley BH, Flaherty JT, Gott VL, Gardner TJ. Oxygen free-radical scavengers protect the arrested, globally ischaemic heart upon reperfusion. Surg Forum 1983; 34: 313-316.
167. Omar BA, McCord JM. The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the post-ischaemic isolated rabbit heart. Free Radic Biol Med 1990; 9: 473-478.
168. Omar BA, Gad NM, Jordan MC et al. Cardioprotection by Cu, Zn-superoxide dismutase is lost at high doses in the neoxygenated heart. Free Radic Biol Med 1990; 9: 465-471.
169. Buchwald A, Klein HH, Lindert S et al. Effect of intracoronary superoxide dismutase on regional function in stunned myocardium. J Cardiovasc Pharmacol 1989 13: 258-264.
170. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986; 74: 1424-1433.
171. Werns SW, Simpson PJ, Mickelso JK, Shea MJ, Pitt B, Lucchesi BR. Sustained by superoxide dismutane of canine myocardial injury due to regional ischaemia followed by refersuion. J Cardiovasc Pharmacol 1988; 11: 36-44.
172. Naslund U, Haggmark S, Johansson G, Marklund SL, Reiz S, Oberg A. Superoxide dismute and catalene reduce infarct size in a porcine myocardial occlusion-reperfusion model. J Mol Cell Cardiol 1989; 1077-1084.
173. Chambers DE, Parks DA, Patterson G et al. Xanthine oxidase as a source of free radical damage in myocardial ischaemia. J Mol Cell Cardiol 1985; 17: 145-152.
174. Downey JM, Miura T, Eddy LJ et al. Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol 1987; 19: 1053-1060.
175. Uraizee A, Reimer KA, Murry CE, Jennings RB. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischaemia and 4 days of reperfusion in dogs. Circulation 1987; 75: 1237-1248.
176. Miura T, Yellon DM, Hearse DJ, Downey JM. Determinants of infarct size during permanent occlsuion of a coronary arter in the closed chest dog. J Am Coll Cardiol 1989; 9: 647-654.
177. Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarction caused by 90 minutes of ischaemia in dogs. Circulation 1988; 78: 473-480.
178. Shuter SL, Davies MJ, Garlick PB, Hearse DJ, Slater TF. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy. Free Radic Res Commun 1990; 9: 223-232.
179. Headrick JP, Armiger LC, Willis RJ. Behaviour of energy metabolites and effect of allopurinol in the stunned isovolumic rat heart. J Mol Cell Cardiol
180. Hearse DJ, Manning AS, Downey JM, Yellon DM. Xanthine oxidase: a critical mediator of myocardial injury during ischaemia and reperfusion. Acta Physiol Scand 1986; 548: 65-74.
181. Matsuki T, Shirato C, Cohen MV, Downey JM. Oxypurinol limits myocardial infarct size in closed chest dogs without pre-treatment. Can J Cardiol 1990; 6: 123-129.
182. Godin DV, Bhimji S. Effects of allopurinol on myocardial ischaemic injury induced by coronary artery ligation and reperfusion. Biochem Pharmacol 1987; 36: 2101-2107.
183. Axford-Gatley RA, Wilson JG. Reduction of experimental myocardial infarct size by oral administration of alpha-tocopherol. Cardiovasc Res 1991; 25: 89-92.
184. Petty MA, Dow J, Grisar JM, De-Jong W Effect of a cardioselective alpha-tocopherol analogue on reperfusion injury in rats induced by myocardial ischaemia. Eur J Pharmacol 1991; 192: 383-388.
185. Haramaki N, Packer L, Assadnazari H, Zimmer G. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem Biophys Res Commun 1993; 196: 1101-1107.
186. Delbarre B, Floyd RA, Belbarre G, Calinon F. Glutamate accumulation and increased hydroxyl free radical formation in the abdominal aorta and heart of the gerbil after ischemia/reperfusion insult. Free Radic Biol Med 1992; 13: 31-34.
187. Nayler WG. Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists. Drugs 1991; 42: 21-27.
188. Nayler WG. The molecular basis for the use of calcium antagonists in ischaemic heart disease. Drugs 1992; 43: 21-27.
189. Baxter GF, Yellon DM. Attenuation of reperfusion-induced ventricular fibrillation in the rat isolated hypertropied heart by preischaemic diltiazem treatment. Cardiovasc Drugs Ther 1993; 7: 225-231.
190. Kimura Y, Engelman RM, Rousou J, Flack J, Iyengar J, Das DK. Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition. Heart Vessels 1992; 7: 189-195.
191. Ferrari R, Visioli O. Calcium channel blockers and ischaemic heart disease: theoretical expectations and clinical experience. Eur Heart J 1991; 12 [Suppl.F]: 18-24.
192. Przyklenk K, Kloner RA. Effect of verapamil on post-ischaemic 'stunned' myocardium: importance of timing of treatment. J Am Coll Cardiol 1988; 11: 614-623.
193. Sassen LM, Bezstarosti K, Verdouw PD, Lamers JM. Effects of nisoldipine on recovery of coronary blood flow, sarcoplasmic reticulum function and other biochemical parameters in post-ischaemic porcine myocardium. Biochem Pharmacol 1991; 41: 43-51.
194. Wolfe CL, Donnelly TJ, Sievers R, Parmley WW. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia. Cardiovasc Res 1991; 25: 101-109.
195. Rousseau G, St. Jean G, Latour JG, Merhi Y, Nattel S, Waters D. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium. Cardiovasc Res 1991; 25: 319-329.
196. Mak IT, Boehme P, Weglicki WP. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res 1992; 70: 1099-1103.
197. Danish Study Group On Verapamil In Myocardial Infarction. Effect of verapamil on mortality and major events after myocardial infarction (The Danish Verapamil Infarction Trial II DAVIT II). Am J Cardiol 1990; 66: 779-785.
198. Chopra M, McMurray J, Stewart J, Dargie HJ, Smith WE. Free radical scavenging: potentially beneficial action of thiol-containing angiotensin-converting enzyme inhibitors. Biochem Soc Trans 1990; 18: 1184-1185.
199. McMurray J, Chopra M. Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope? Br J Clin Pharmacol 1991; 31: 373-379.
200. Huizer T, van der Meer P, de-Jong JW. Captopril inhibits angiotensin I-induced coronary flow reduction in isolated rat heart but has no effect on contractility or energy metabolism. Eur Heart J 1992; 13: 109-114.
201. Przyklenk K, Kloner RA. Angiotensin-converting enzyme inhibitors enhance contractile function of 'stunned' myocardium by different mechanisms of action. Circulation 1990; 82: 264 [abstract].
202. Mehta PM, Przyklenk K, Kloner RA. Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/ reperfusion and infarction. Eur Heart J 1990; 11: 94-99.
203. Di Pasquale P, Paterna S, Cannizzaro S, Bucca V. Does captorpil treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-tern and long-term effects. Int J Cardiol 1994; 43: 43-50.
204. Cleland JGF, Bulpitt CJ, Falk RH et al. Is aspirin safe for patients with heart failure? Br Heart J 1995; 74: 215-219.
205. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of CONSENSUS II. N Engl J Med 1992; 327: 678-684.
206. Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, Normandin D, Antonaccio MJ, Grover GJ. Cardioprotection in ischemic rat hearts with the SH-containing ACE inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel. J Pharmacol Exp Ther 1993; 265: 609-618.
207. Nishinaka Y, Kitahara S, Sugiyama S, Yokota M, Saito H, Ozawa T. The cardioprotective effect of gamma-glutamylcysteine ester during coronary reperfusion in canine hearts. Br J Pharmacol 104: 805-810.
208. Udupi V, Rice-Evans C. Thiol compounds as protective agents in erythrocytes under stress. Free Radic Res Commun 1992; 16: 315-323.
209. Ceconi C et al. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetylcysteine. J Mol Cell Cardiol 1988; 20: 5-13.
210. Such L, Morcillo E, Chorro FJ et al. Beneficial effects of N-acetylcysteine on acute myocardial infarctionin open chest dogs. Arch Pharmacol Toxicol 1986; 12: 37-40.
211. Forman MB, Puett DW, Cates CU et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1988; 78: 202-213.
212. Boesgaard S et al. Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerine infusion in an in vivo rat model. J Pharmacol Exp Ther 1991; 258: 851-856.
213. Angel MF, Narayanan K, Swartz NM et al. Desferoxamine increases skin flap survival: additional evidence of free radical involvement in ischaemic flap surgery. Br J Plast Surg 1986; 39: 469-472.
214. Bolli R, Patel BS, Zhu WX et al. The iron chelator desferioxamine attenuates postischaemic ventricular dysfunction. Am J Physiol 1987; 253: H1372-H1380.
215. Reddy BR, Wynne J, Kloner RA, Pryklemk PP. Pretreatment with iron-chelator desferioxamine fails to provide sustained protection against myocardial reperfusion injury. Cardiovasc Res 1991; 25: 711-718.
216. Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987; 110: 13-30.
217. Klein HH, Pich S, Bohle RM et al. Anti-inflammatory agent BW 755 C in ischaemic reperfused porcine hearts. J Cardiovasc Pharmacol 1988; 12: 338-344.
218. O'Neill PG, Charlat ML, Kim HS et al. Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction. Cardiovasc Res 1987; 21: 755-760.
219. Ravingerova T, Styk J, Tregerova V, Pancza D, Slezak J, Tribulova N et al. Protective effect of 7-oxo-prostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol 1991; 86: 245-253.
220. Conorev EA, Sharov VG, Saks VA. Improvement of contractile recovery of isolated rat heart after cardioplegic ischaemic arrest with endogenous phosphocreatine: involvement of antiperoxidative effect? Cardiovasc Res 1991; 25: 164-171.
221. Allen CB, Saari JT. Isolated hearts from copper-deficient rats exhibit improved postischaemic contractile performance. J Nutr 1993; 123: 1794-800.
222. Powell SR, Hall D, Shih A. Copper loading of hearts increases postischemic reperfusion injury. Circ Res 1991; 69: 881-885.
223. du Toit EF, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 1992; 70: 960-967.
224. Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991; 32: 3-10.
225. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-1558.
226. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-685.
227. Galløe AM, Rasmussen HS, Jørgensen LN et al. Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction. Br Med J 1993; 307: 585-587.
228. Tanaka J, Rominaga R, Yoshitoshi M et al. Coenzyme Q10: the prophylactic effect on low cardiac output following cardiac valve replacement. Ann Thorac Surg 1981; 33: 145-151.
229. Powell WJ, DiBona DR, Flores J et al. The protective effect of hyperosmolar mannitol in myocardial ischaemia and necrosis. Circulation 1976; 54: 603-615.
230. Riva E, Leopaldi D. Control of the cardiac consequences of myocardial ischaemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart. Pediatr Res 1993; 34: 465-470.
231. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP, Lucchesi BR. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion. Cire Res 1988; 63: 1070-1079.
232. McFalls EO, Duncker DJ, Krams R, Ward H, Gornick C, Verdouw PD. Endothelium dependent vasodilatation following brief ischaemia and reperfusion in anaesthetised swine. Cardiovasc Res 1991; 25: 659-665.
233. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial stunning in the dog. Circ Res 1995; 76: 82-94.
234. Dage RC, Anderson BA, Mao SJ, Koerner JE. Probucol reduces myocardial dysfunction during reperfusion after short term ischemia in rabbit heart. J Cardiovasc Pharmacol 1991; 17: 158-165.
235. Hultzquist DE, Xu F, Quandt KS, Shlafer M, Mack CP, Till GO, Seekamp A, Betz AL, Ennis SR. Evidence that NADPH-dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury. Am J Hematol 1993; 42: 13-18.
236. Guvendik L, Hynd J, Drake-Holland A, Parker DJ. Myocardial protective effects of lidoflazine during ischaemia and reperfusion. Thorac Cardiovasc Surg 1990; 38: 15-19.
237. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.